David Fudman, MD
@fudmanMD
Followers
2K
Following
2K
Media
91
Statuses
1K
Gastroenterologist with focus on #IBD and quality improvement @UTSWmedcenter (Tweets mine, not medical advice, of course)
Dallas, TX
Joined February 2019
In this month's Perspectives column, Dr. Anahita Rabiee and Dr. Tarek Sawa discuss approaches to esophageal varices and Barrett’s esophagus, highlighting shifts in screening, surveillance, & innovation in GI care. 🔗 Read more: https://t.co/wrcr5kvjom
1
4
4
Helpful citation! A topic of one our our cases in IBD conference just recently @MohebBoktorMD @GIJamesMD @UTSWGI
MRI for Distinguishing Perianal Hidradenitis Suppurativa From Fistulizing Crohn Disease https://t.co/HIv5RGaiCb
@AfsanehAlavi @MikaTakaichi
0
2
10
Check out practical advice 📝 on Monitoring Inflammatory Bowel Disease Activity: When, How, and Why In @AmCollegeGastro @AmJGastro with @JillGaidosMD ✅ for: 🚽🩸Clinical response and remission 🧪💩💉Biochemical 🧐🔎🔬Endoscopic 🩻 Radiographic https://t.co/bJQyNPJnvh
1
35
78
🗞️Check out the #REACHIBD summer newsletter for #GI fellows and early-career #IBD pros. Insightful patient stories, ☀️ #stoma tips to share, and more! @fudmanMD @tqaziMD @GutlessGlamour @esna_mary @IBDProNews @CrohnsColitisFn
https://t.co/8rI6nkYgjI
0
10
21
Appropriate use and complications of corticosteroids in inflammatory bowel disease: A comprehensive review - Clinical Gastroenterology and Hepatology
cghjournal.org
Corticosteroids are one of the most frequently prescribed medications for the management of inflammatory bowel disease. Although corticosteroids have a critical role for select cases for induction of...
1
4
17
Thanks to @medpagetoday for the great questions highlighting our review on modern therapies for #IBD
https://t.co/lNaytwUzYq
https://t.co/aA3MlU6Qvs
medpagetoday.com
The last half decade has seen a rapid expansion of inflammatory bowel disease (IBD) treatments based on novel biological effects. Among these are oral small-molecule Janus kinase (JAK) inhibitors,...
0
9
18
Great to see this work out. We found no evidence of a causal relationship between most medications and risk of microscopic colitis (MC) among older adults challenging the established paradigm that MC is a medication-induced colitis. @NIH @NIHAging @MGH_CTEU @MGBResearchNews
A target trial emulation found no evidence of a causal relationship between most previously suspected medications, including #statins and NSAIDs, and #MicroscopicColitis in older adults. https://t.co/91lVXra4CK
@ludvigsson @karolinskainst @khalili_MD @MGH_CTEU @harvardmed
1
5
18
It was a pleasure to speak with GI Insights @ReachMD on navigating the expanding therapeutic landscape for #IBD "Tailoring Inflammatory Bowel Disease Care: Selection Criteria and Timing" https://t.co/oTmhqhhWPn
2
2
11
2
7
34
Preconception planning reviewed by @IBD_Houston during #aibdregionals @IBDConference @AmCollegeGastro
0
16
41
It's prime time to address barriers to advanced therapy. Despite their indication and availability, they are still underutilized. Studies have shown that the use of biologic therapy is related to improved outcomes (less bowel damage, therapy escalation, and surgery)
4
12
29
Impactful morning w #REACHIBD @IBDProNews 💎Representation matters to⏩science & health equity @SandraQuezadaMD 💎Steps to be an effective advocate from clinic to the 🏛️ @ariel_jordan22 💎What does it mean to b a leader @IBDMD 💎Design your own career path & develop your brand🙋🏽♀️
1
10
33
0
1
2
🪨⭐️ team on this review of what we know so far about using IL23s to treat #IBD 🙏for the great work!
If you’re curious about all the new IL-23 inhibitors for IBD and why you might choose one over the other, check out our newly published review on this topic! Thank you @fudmanMD for your guidance on this article. Full text link ➡️
2
2
8
🚨#GIFellow & early-career GI (ie all the 😎🩺) Don’t miss this 🆓💎🌟🆓 #IBDReach edunetworking webinar: Empowering the next gen of #IBD leaders 🗓️June 7, 8am PT/11am ET 🌟Faculty for 👌🏽agenda👇🏽 💎Curated by @nloganmd & #MichelleRosario 🔗Register https://t.co/KHZI9eCtMM
💡#IBD career insights. 🎤Leadership lessons. 🗣️Real talk with @SandraQuezadaMD, @ariel_jordan22, @DCharabaty, and @IBDMD! This FREE #REACHIBD virtual event is for YOU! 📅 Sat, June 7 | ⏰ 11AM ET 🎓 Fellows & early-career GIs welcome!
0
14
40
Register: https://t.co/G26JX96FbS ✅ Navigating barriers of care with @SandraQuezadaMD ✅ Amplifying your voice in healthcare with Dr. Ariel Jordan ✅ Navigating your path from fellowship to leadership with @DCharabaty ✅ Building skills for long-term success with @IBDMD
on-line.crohnscolitisfoundation.org
The mission of the Crohn's & Colitis Foundation is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation...
0
3
7
🚨REACH-IBD Career Development Event 🚨 Empowering the Next Generation of IBD Experts: Exclusive Roundtable with Leaders in IBD ⏲6/7/25 11-1:30 EST 📢Sandra Quezada, David Rubin, Aline Charabaty, Ariel Jordan Registration below👇
1
1
5
Building a program isn't just about being able to do a procedure. I was messaged asking about resection after this lesion was found on FIT+ colon. Years of communication, education, & discussion about what our #ThirdSpace program has to offer led to this patient having a
13
13
138
What a pleasure to have you @IBD_Houston ! Thanks for making the cross state journey 😃
Thanks for the invitation for #GrandRounds @UTSWMedCenter in educating GI fellows and faculty on the utility of #IUS in #IBD. @MohebBoktorMD @fudmanMD @ezraburstein. Beautiful campus: it confirms everything is bigger in Texas!
0
1
5